GlassScriptPhysician profile
Michael K Louie
NPI 1538294798
$2,976.52
in general payments reported to CMS, 2019-2025
13 companies · $39.70 in 2025
The $39.70 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.00 · 2020: $47.74 · 2021: $387 · 2022: $814 · 2023: $1,326 · 2024: $318 · 2025: $39.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,107 · Travel and Lodging: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,107.26 |
| Travel and Lodging | $576.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,309.22 | 2022-2023 | Soltive |
| Procept Biorobotics Corporation | $798.79 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Medtronic, INC. | $205.43 | 2021-2023 | Interstim |
| Boston Scientific Corporation | $169.94 | 2019-2023 | Ams 700 |
| Photocure INC | $120.07 | 2024 | Cysview |
| Astellas Pharma US INC | $96.17 | 2020-2022 | |
| Allergan, INC. | $79.80 | 2019-2021 | |
| Pfizer INC. | $52.61 | 2020-2021 | |
| Hollister Incorporated | $39.29 | 2021 | |
| Antares Pharma, INC. | $35.54 | 2021-2022 | |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Urovant Sciences INC | $23.00 | 2021 | |
| Endo Pharmaceuticals INC. | $22.73 | 2023 | Xiaflex, Aveed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Louie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.